<SEC-DOCUMENT>0001213900-24-085211-index.html : 20241004
<SEC-HEADER>0001213900-24-085211.hdr.sgml : 20241004
<ACCEPTANCE-DATETIME>20241004083030
ACCESSION NUMBER:		0001213900-24-085211
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20241004
FILED AS OF DATE:		20241004
DATE AS OF CHANGE:		20241004

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AKANDA CORP.
		CENTRAL INDEX KEY:			0001888014
		STANDARD INDUSTRIAL CLASSIFICATION:	MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			A6
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41324
		FILM NUMBER:		241353609

	BUSINESS ADDRESS:	
		STREET 1:		1A, 1B LEAROYD ROAD
		CITY:			NEW ROMNEY
		STATE:			X0
		ZIP:			TN28 8XU
		BUSINESS PHONE:		442034889514

	MAIL ADDRESS:	
		STREET 1:		77 KING STREET WEST, SUITE 400
		STREET 2:		C/O DENTONS CANADA LLP
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M5K 0A1
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>ea0216708-6k_akanda.htm
<DESCRIPTION>REPORT OF FOREIGN PRIVATE ISSUER
<TEXT>
Document 1 - file: ea0216708-6k_akanda.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>ea021670801ex1-1_akanda.htm
<DESCRIPTION>UNDERWRITING AGREEMENT DATED OCTOBER 2, 2024
<TEXT>
Document 2 - file: ea021670801ex1-1_akanda.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>3
<FILENAME>ea021670801ex4-1_akanda.htm
<DESCRIPTION>FORM OF PRE-FUNDED WARRANT
<TEXT>
Document 3 - file: ea021670801ex4-1_akanda.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>4
<FILENAME>ea021670801ex99-1_akanda.htm
<DESCRIPTION>PRESS RELEASE DATED OCTOBER 4, 2024
<TEXT>
Document 4 - file: ea021670801ex99-1_akanda.htm

</DOCUMENT>
</SEC-DOCUMENT>